Reyes Financial Architecture
IBB icon

Reyes Financial Architecture’s iShares Biotechnology ETF IBB Stock Holding History

Reyes Financial Architecture’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-52,885
Closed -$10.1M – 559
2026
Q2 		$10.1M Buy
+52,885
New +$9.09M 5.63% 4
2026
Q1 		– Sell
-730
Closed -$123K – 391
2025
Q4 		$123K Hold
730
– – 0.08% 97
2025
Q3 		$105K Buy
+730
New +$100K 0.07% 118
2025
Q2 		– Sell
-45
Closed -$5.76K – 309
2025
Q1 		$5.76K Hold
45
– – ﹤0.01% 257
2024
Q4 		$5.95K Buy
+45
New +$6.33K ﹤0.01% 230

Other funds holding IBB

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
WestEnd Advisors
WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Albion Financial Group
Albion Financial Group Salt Lake City, Utah $1.77B AUM 14.95% 1-Year Est. Return

Reyes Financial Architecture's IBB Position: Q3 2026 in Review

Reyes Financial Architecture sold out of iShares Biotechnology ETF (IBB) in Q3 2026, closing a stake of 52,885 shares — an estimated $10.1M sold.

Reyes Financial Architecture first reported a position in IBB in Q4 2024 and held it in 5 quarters. The position peaked at $10.1M in Q2 2026. 646 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Reyes Financial Architecture reported no remaining iShares Biotechnology ETF position as of Q3 2026 after selling out during the quarter.
  • Reyes Financial Architecture sold 52,885 iShares Biotechnology ETF shares in Q3 2026, an estimated $10.1M.
  • Reyes Financial Architecture first reported a position in iShares Biotechnology ETF in Q4 2024 and held it in 5 quarters.
  • Reyes Financial Architecture's iShares Biotechnology ETF position peaked at $10.1M in Q2 2026.
  • 646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Reyes Financial Architecture's 13F filing for Q3 2026, filed 22 Oct 2026.